AB
Amalgamated Bank Portfolio holdings
AUM
$13B
1-Year Return
23.92%
This Quarter Return
-2.57%
1 Year Return
+23.92%
3 Year Return
+105.94%
5 Year Return
+196.1%
10 Year Return
+496.3%
AUM
$11.7B
AUM Growth
-$612M
(-5%)
Cap. Flow
-$149M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
3,057
New
16
Increased
865
Reduced
980
Closed
32
Top Buys
| 1 |
Blackstone
BX
|
+$11.7M |
| 2 |
Airbnb
ABNB
|
+$9.16M |
| 3 |
Kenvue
KVUE
|
+$8.87M |
| 4 |
Gaming and Leisure Properties
GLPI
|
+$6.07M |
| 5 |
Equity Lifestyle Properties
ELS
|
+$5.75M |
Top Sells
| 1 |
Apple
AAPL
|
+$30.8M |
| 2 |
Microsoft
MSFT
|
+$27.7M |
| 3 |
Visa
V
|
+$13.7M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$13.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$12.3M |
Sector Composition
| 1 | Technology | 26.24% |
| 2 | Healthcare | 12.71% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 11.6% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Stellar Bancorp
STEL
$1.61B
| $395K | ﹤0.01% |
18,521
| – | – |
|
1527
Comstock Resources
CRK
$4.67B
| $394K | ﹤0.01% |
35,738
-1,095
| -3% | -$12.1K |
|
1528
John B. Sanfilippo & Son
JBSS
$737M
| $392K | ﹤0.01% |
3,969
-116
| -3% | -$11.5K |
|
1529
ANI Pharmaceuticals
ANIP
$2.12B
| $390K | ﹤0.01% |
6,722
+692
| +11% | +$40.1K |
|
1530
FB Financial Corp
FBK
$2.86B
| $390K | ﹤0.01% |
13,740
-451
| -3% | -$12.8K |
|
1531
Safety Insurance
SAFT
$1.1B
| $390K | ﹤0.01% |
5,721
-214
| -4% | -$14.6K |
|
1532
Acadia Pharmaceuticals
ACAD
$3.98B
| $389K | ﹤0.01% |
18,685
+276
| +1% | +$5.75K |
|
1533
Pegasystems
PEGA
$9.93B
| $389K | ﹤0.01% |
17,930
-362
| -2% | -$7.85K |
|
1534
WisdomTree
WT
$2.11B
| $388K | ﹤0.01% |
55,371
| – | – |
|
1535
Ligand Pharmaceuticals
LGND
$3.23B
| $386K | ﹤0.01% |
6,449
-241
| -4% | -$14.4K |
|
1536
ProAssurance
PRA
$1.22B
| $386K | ﹤0.01% |
20,448
-1,272
| -6% | -$24K |
|
1537
CBIZ
CBZ
$3.01B
| $385K | ﹤0.01% |
7,413
+139
| +2% | +$7.22K |
|
1538
Krystal Biotech
KRYS
$4.16B
| $385K | ﹤0.01% |
3,320
+41
| +1% | +$4.76K |
|
1539
NovoCure
NVCR
$1.36B
| $385K | ﹤0.01% |
23,847
+1,072
| +5% | +$17.3K |
|
1540
Customers Bancorp
CUBI
$2.32B
| $383K | ﹤0.01% |
11,131
-734
| -6% | -$25.3K |
|
1541
McGrath RentCorp
MGRC
$3.01B
| $383K | ﹤0.01% |
3,816
+75
| +2% | +$7.53K |
|
1542
Akero Therapeutics
AKRO
$3.48B
| $382K | ﹤0.01% |
7,559
+1,166
| +18% | +$58.9K |
|
1543
Caleres
CAL
$503M
| $382K | ﹤0.01% |
13,291
-1,111
| -8% | -$31.9K |
|
1544
Veritex Holdings
VBTX
$1.88B
| $379K | ﹤0.01% |
21,111
-333
| -2% | -$5.98K |
|
1545
Denali Therapeutics
DNLI
$2.07B
| $377K | ﹤0.01% |
18,255
+679
| +4% | +$14K |
|
|
INVX
1546
Innovex International, Inc.
INVX
$1.14B
| $376K | ﹤0.01% |
13,330
-443
| -3% | -$12.5K |
|
|
ARR
1547
Armour Residential REIT
ARR
$1.72B
| $374K | ﹤0.01% |
17,619
+2,407
| +16% | +$51.1K |
|
1548
Braze
BRZE
$3.35B
| $374K | ﹤0.01% |
7,994
+2,759
| +53% | +$129K |
|
|
CHS
1549
DELISTED
Chicos FAS, Inc.
CHS
| $370K | ﹤0.01% |
49,400
| – | – |
|
|
AAT
1550
American Assets Trust
AAT
$1.27B
| $369K | ﹤0.01% |
18,984
-1,735
| -8% | -$33.7K |
|